Pharmacokinetics and metabolism of RU 486.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Steroid Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-4731(87)90160-9PMID 3695508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.

  1987cited by this paper
• Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography.

  1986cited by this paper
• Pharmacokinetics of RU 486.

  1985cited by this paper
• Interruption of early pregnancy by an anti-progestational compound, RU 486.

  1985cited by this paper
• Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.

  1985cited by this paper
• Radioimmunoassay of RU 486

  1985cited by this paper
• The new steroid analog RU 486 inhibits glucocorticoid action in man.

  1984cited by this paper
• [The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy].

  1982cited by this paper
• Binding of progesterone by rat myometrium during pregnancy and by human myometrium in late pregnancy.

  1974cited by this paper

• Similarities and differences between embryonic implantation and CTC invasion: Exploring the roles of abortifacients in cancer metastasis chemoprevention.

  2022cites this paper
• Combination of mifepristone and misoprostol in medical abortion in the first trimester of pregnancy

  2021cites this paper
• The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity

  2020cites this paper
• Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility

  2020cites this paper
• Inhibition of adenovirus infection by mifepristone

  2018cites this paper
• Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer.

  2018cites this paper
• Stress affects expression of the clock gene Bmal1 in the suprachiasmatic nucleus of neonatal rats via glucocorticoid‐dependent mechanism

  2018cites this paper
• Pharmacokinetic differences of mifepristone between sexes in animals

  2018cites this paper
• Resetting the Stress System with a Mifepristone Challenge

  2018cites this paper
• Drug Methods for Arteficial Termination of Unwanted Pregnancy

  2018cites this paper
• Chlorpyrifos and lambda cyhalothrin-induced oxidative stress in human erythrocytes

  2017influential citation
• ROLE OF ORAL MIFEPRISTONE AS A CERVICAL PRIMING AGENT FOR INDUCTION OF LABOUR

  2017cites this paper
• Shorter time interval treatments for early medical abortions : a mixed methods research approach

  2017cites this paper
• Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures.

  2017influential citation
• Synthesis of metapristone through an efficient N-demethylation of mifepristone

  2016cites this paper
• Thirty-day rat toxicity study reveals reversible liver toxicity of mifepristone (RU486) and metapristone

  2016cites this paper
• Early versus late misoprostol administration after mifepristone for medical abortion

  2015cites this paper
• Investigation of the Hypoglycemic and Antioxidant Effects of Lycopene in Chlorpyrifos-Ethyl Treated Diabetic Rats

  2015cites this paper
• Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke.

  2014cites this paper
• Misoprostol as a family planning drug : use in pregnant and non-pregnant women

  2014cites this paper
• Studies in reproductive endocrinology

  2014cites this paper
• The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis

  2014cites this paper
• The role of the endocannabinoid system in fertility control

  2013cites this paper
• The Relative Importance of CYP26A1 and CYP26B1 in Mediating Retinoid Homeostasis: Studies on the Formation, Elimination and Biological Activity of All-trans-Retinoic Acid Metabolites

  2013influential citation
• Blood group porphyrins in lipid-protein model systems: Preferential solvation of hematoporphyrin in 1-octanol-N,N-dimethylformamide mixtures

  2012cites this paper
• The use of mifepristone in the treatment of Cushing's syndrome.

  2012cites this paper
• Spatial memory processes in bipolar depression : neuropsychological and HPA axis correlates

  2011cites this paper
• Emergency contraception: presently available formulations and controversies surrounding their use

  2011cites this paper
• Seletracetam (UCB 44212)

  2011cites this paper
• Digoxin therapy in the elderly: pharmacokinetic considerations in nursing.

  2011cites this paper
• Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.

  2010cites this paper
• Medical abortion in lactating women – low levels of mifepristone in breast milk

  2010cites this paper
• In Vitro-In Vivo Correlation and Translation to the Clinical Outcome for CJ-13,610, a Novel Inhibitor of 5-Lipoxygenase

  2010cites this paper
• Analysis of Progestagens

  2010cites this paper
• The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(−/−) Mice

  2009cites this paper
• Medical Abortion in Early Pregnancy

  2009cites this paper
• Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study.

  2009influential citation
• Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.

  2009cites this paper
• Effects of endogenous glucocorticoids on allergic inflammation and T(H)1 /T(H)2 balance in airway allergic disease.

  2009cites this paper
• Clinical, biochemical and morphological aspects of cervical ripening in the first trimester

  2009cites this paper
• Bioavailability of mifepristone in capsule versus tablet form in healthy nonpregnant women.

  2008cites this paper
• Selective Serotonin Reuptake Inhibitor and Substance P Antagonist Enhancement of Natural Killer Cell Innate Immunity in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome

  2008cites this paper
• Emergency contraception: A review

  2008cites this paper
• Mifepristone (RU 486) in Cushing's syndrome.

  2007cites this paper
• One or two day mifepristone–misoprostol interval for second trimester abortion

  2007cites this paper
• Cannabinoids and Multiple Sclerosis

  2007cites this paper
• Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?

  2007cites this paper
• Mid-trimester induced abortion: a review.

  2007influential citation
• Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression.

  2007cites this paper
• Misoprostol : Pharmacokinetics and effects on uterine contractility and cervival ripening in early pregnancy

  2007cites this paper
• Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.

  2007cites this paper
• Bioavailability of a silybin-phosphatidylcholine complex in dogs.

  2007cites this paper
• A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

  2007cites this paper
• Low Dose Mifepristone And Vaginal Misoprostol: A Safe Option For Termination Of Pregnancy Up To 63 Days

  2006cites this paper
• Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications

  2006cites this paper
• Contraception Today

  2006cites this paper
• Review of medical abortion using mifepristone in combination with a prostaglandin analogue.

  2006influential citation
• Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans

  2005cites this paper
• Male Hypogonadism

  2005cites this paper
• Hematosalpinx: an unusual complication after medical abortion with oral mifepristone and misoprostol

  2005cites this paper
• Pharmacokinetic studies with PET.

  2005cites this paper
• Clinical Applications of Progesterone Receptor Antagonists and Selective Progesterone Receptor Modulators

  2005cites this paper
• Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells.

  2004cites this paper
• Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.

  2004cites this paper
• Effects of onapristone on postmenopausal endometrium.

  2003cites this paper
• Emergency contraception—clinical and ethical aspects

  2003cites this paper
• Current medical abortion care.

  2003cites this paper
• Pharmacokinetics and metabolism of endothelin receptor antagonist: Contribution of kidneys in the overallin vivo N-demethylation

  2003cites this paper
• Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis

  2003cites this paper
• Molecular-epidemiological aspects of carcinogenesis : the role of xenobiotic metabolizing enzymes *

  2002cites this paper
• Mifepristone followed on the same day by vaginal misoprostol for early abortion.

  2002cites this paper
• Mifepristone followed on the same day by vaginal misoprostol for early abortion ∗ ∗ This document includes a discussion of use of a product that is unapproved by the U.S. Food and Drug Administration.

  2001cites this paper
• Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.

  2001cites this paper
• Mifepristone 100 mg in Abortion Regimens

  2001cites this paper
• Mifepristone

  2001cites this paper
• Mifepristone: a potential postcoital contraceptive

  2001cites this paper
• Hormones, Sex Hormones

  2000cites this paper
• Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration.

  2000cites this paper
• Mifepristone and misoprostol

  1999cites this paper
• In vitro metabolism of mifepristone (RU-486) in rat, monkey and human hepatic S9 fractions: identification of three new mifepristone metabolites.

  1999cites this paper
• The Progesterone Blockade of the Luteinizing Hormone Surge is Overcome by RU486

  1999cites this paper
• The Use of Clobazam, Midazolam, and Nitrazepam in Epilepsy

  1998cites this paper
• Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4

  1998cites this paper
• Safety, tolerability, and pharmacokinetics of a novel, selective antiprogestagen (Org 31710) in healthy male volunteers.

  1998cites this paper
• Effects and metabolism of steroid hormones in human neuroblastoma cells.

  1998cites this paper
• Antiprogestin Pharmacodynamics, Pharmacokinetics, and Metabolism: Implications for Their Long-Term Use

  1997cites this paper
• Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils.

  1997cites this paper
• DISPOSITION AND METABOLISM OF 2 , 6-DIMETHYLBENZAMIDE N-( 5-METHYL-3-ISOXAZOLYL ) ( D 2916 ) IN MALE AND FEMALE RATS

  1997cites this paper
• Protection Against Oxidative Stress‐induced Neuronal Cell Death‐A Novel Role for RU486

  1997cites this paper
• Mifepristone (RU486): a review.

  1997cites this paper
• Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486.

  1996cites this paper
• Mifepristone: antineoplastic studies.

  1996cites this paper
• The antiglucocorticoid action of mifepristone.

  1996cites this paper
• Determination of RU486 (mifepristone) in blood by radioreceptorassay; a pharmacokinetic study.

  1996cites this paper
• The antiglucocorticoid action of mifepristone.

  1996cites this paper
• Determination of RU486 (Mifepristone) in Blood by Radioreceptorassay; A Pharmacokinetic Study

  1996cites this paper
• Analysis of progestogens

  1995cites this paper
• Effect of RU‐486 and Related Compounds on the Proliferation of Cultured Macrophages

  1995cites this paper
• The Glucocorticoid Receptor and RU 486 in Man

  1995cites this paper
• Growth inhibition of androgen‐insensitive human prostate carcinoma cells by a 19‐norsteroid derivative agent, mifepristone

  1995cites this paper